Organization Overview
Alternative names
bevacizumab (avastin) (1 trial)
bleomycin (blenoxane) (2 trials)
carboplatin (paraplatin) (3 trials)
cisplatin (platinol) (11 trials)
doxorubicin (Doxil) (4 trials)
durvalumab (imfinzi) (1 trial)
fluorouracil (efudex) (5 trials)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Colorectal Neoplasms (Phase 3)
Esophageal Neoplasms (Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 3)
Fallopian Tube Neoplasms (Phase 2)
Glioblastoma (Phase 3)
Leukemia (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 3)
Leukemia, T-Cell (Phase 3)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, Non-Hodgkin (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Second Primary (Phase 3)
Ovarian Neoplasms (Phase 2)
Pancoast Syndrome (Phase 2)
Pericardial Effusion (Phase 3)
Peritoneal Neoplasms (Phase 2)
Recurrence (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Stomach Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)